Increased Circulating Erythrocyte-Derived Microparticles in Patients with Acute Coronary Syndromes

References

• Go AS , MozaffarianD, RogerVLet al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation127(1), 143–152 (2013).
   PubMed Web of Science ®Google Scholar
• Agnello L , BelliaC, ScazzoneCet al. Establishing the 99th percentile for high sensitivity cardiac troponin I in healthy blood donors from Southern Italy. Biochem. Med. (Zagreb)29(2), 020901 (2019).
   PubMed Web of Science ®Google Scholar
• Bivona G , AgnelloL, BelliaCet al. Diagnostic and prognostic value of H-FABP in acute coronary syndrome: still evidence to bring. Clin. Biochem.58, 1–4 (2018).
   PubMedGoogle Scholar
• CImen AO , EmetS, ElitokA. Endocan: a biomarker predicting successful reperfusion after coronary artery by-pass surgery of acute coronary syndrome patients. Eur. Rev. Med. Pharmacol. Sci.23(1), 338–342 (2019).
   PubMed Web of Science ®Google Scholar
• Zlinellu A , SotgiaS, PorcuPet al. Carotid restenosis is associated with plasma ADMA concentrations in carotid endarterectomy patients. Clin. Chem. Lab. Med.49(5), 897–901 (2011).
   PubMedGoogle Scholar
• Cavusoglu E , RuwendeC, ChopraVet al. Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography. Coron. Artery Dis.20(2), 112–117 (2009).
   PubMedGoogle Scholar
• Mause SF . Platelet microparticles: reinforcing the hegemony of platelets in atherothrombosis. Thromb. Haemost.109(1), 5–6 (2013).
   PubMedGoogle Scholar
• Suades R , PadróT, VilahurGet al. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb. Haemost.108(6), 1208–1219 (2012).
   PubMed Web of Science ®Google Scholar
• Diamant M , TushuizenME, SturkAet al. Cellular microparticles: new players in the field of vascular disease? Eur. J. Clin. Invest. 34(6), 392–401 (2004).
   PubMed Web of Science ®Google Scholar
• Allan D , ThomasP, LimbrickAR. The isolation and characterization of 60 nm vesicles (‘nanovesicles’) produced during ionophore A23187-induced budding of human erythrocytes. Biochem. J.188(3), 881–887 (1980).
   PubMed Web of Science ®Google Scholar
• El-Menshawy N , EissaM, FaragRet al. CD235a (Glycophorin-A) is the most predictive value among different circulating cellular microparticles in thrombocytopenic human immunodeficiency virus Type 1. J. Clin. Lab. Anal.30(3), 235–243 (2016).
   PubMedGoogle Scholar
• Barr JD , ChauhanAK, SchaefferGVet al. Red blood cells mediate the onset of thrombosis in the ferric chloride murine model. Blood121(18), 3733–3741 (2013).
   PubMed Web of Science ®Google Scholar
• Risbano MG , KaniasT, TriulziDet al. Effects of aged stored autologous red blood cells on human endothelial function. Am. J. Respir. Crit. Care Med.192(10), 1223–1233 (2015).
   PubMedGoogle Scholar
• Camus SM , GausserèsB, BonninPet al. Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease. Blood120(25), 5050–5058 (2012).
   PubMedGoogle Scholar
• Roffi M , PatronoC, ColletJPet al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J.37(3), 267–315 (2016).
   PubMed Web of Science ®Google Scholar
• Gensini GG . A more meaningful scoring system for determining the severity of coronary heart disease. Am. J. Cardiol.51(3), 606 (1983).
   PubMed Web of Science ®Google Scholar
• Bernal-Mizrachi L , JyW, JimenezJJet al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am. Heart J.145(6), 962–970 (2003).
   PubMed Web of Science ®Google Scholar
• Amabile N , GuérinAP, TedguiAet al. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. Nephrol. Dial. Transplant.27(5), 1873–1880 (2012).
   PubMed Web of Science ®Google Scholar
• Feng B , ChenY, LuoYet al. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with Type 2 diabetes mellitus. Atherosclerosis208(1), 264–269 (2010).
   PubMedGoogle Scholar
• Takahashi T , KobayashiS, FujinoNet al. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility. Thorax67(12), 1067–1074 (2012).
   PubMedGoogle Scholar
• Faure V , DouL, SabatierFet al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J. Thromb. Haemost.4(3), 566–573 (2006).
   PubMedGoogle Scholar
• Kozuma Y , SawahataY, TakeiYet al. Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria. Br. J. Haematol.152(5), 631–639 (2011).
   PubMedGoogle Scholar
• Nébor D , RomanaM, SantiagoRet al. Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children. Haematologica98(6), 862–867 (2013).
   PubMed Web of Science ®Google Scholar
• Gao C , XieR, YuCet al. Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome. Thromb. Haemost.107(4), 681–689 (2012).
   PubMedGoogle Scholar
• Marques FK , CamposFM, FilhoOAet al. Circulating microparticles in severe preeclampsia. Clin. Chim. Acta12(414), 253–258 (2012).
   Google Scholar
• Leonetti D , ReimundJM, TesseAet al. Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions. PLoS ONE8(9), e73088 (2013).
   PubMedGoogle Scholar
• Yujuan Y , NijiatiM, ArikinAet al. Comparison of erythrocyte microparticle levels between acute coronary syndrome and stable angina pectoris patients. Int. J. Clin. Exp. Med.11(9), 9528–9535 (2018).
   Google Scholar
• Suades R , PadróT, VilahurGet al. Growing thrombi release increased levels of CD235a(+) microparticles and decreased levels of activated platelet-derived microparticles. Validation in ST-elevation myocardial infarction patients. J. Thromb. Haemost.13(10), 1776–1786 (2015).
   PubMed Web of Science ®Google Scholar
• Giannopoulos G , GeorgiosO, GeorgiosPet al. Red blood cell and platelet microparticles in myocardial infarction patients treated with primary angioplasty. Int. J. Cardiol.176(1), 145–150 (2014).
   PubMed Web of Science ®Google Scholar
• George M , GaneshMR, SridharAet al. Evaluation of endothelial and platelet derived microparticles in patients with acute coronary syndrome. J. Clin. Diagn. Res.9(12), 9–13 (2015).
   Google Scholar
• Bobryshev YV , KillingsworthMC, OrekhovAN. Increased shedding of microvesicles from intimal smooth muscle cells in athero-prone areas of the human aorta: implications for understanding of the predisease stage. Pathobiology80(1), 24–31 (2013).
   PubMedGoogle Scholar
• Leroyer AS , IsobeH, LesècheGet al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J. Am. Coll. Cardiol.49(7), 772–777 (2007).
   PubMed Web of Science ®Google Scholar
• Amabile N , RautouPE, TedguiAet al. Microparticles: key protagonists in cardiovascular disorders. Semin. Thromb. Hemost.36(8), 907–916 (2010).
   PubMed Web of Science ®Google Scholar
• Koshiar RL , SomajoS, NorströmEet al. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation. PLoS ONE9(8), e104200 (2014).
   PubMed Web of Science ®Google Scholar
• Biró E , Sturk-MaquelinKN, VogelGMet al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J. Thromb. Haemost.1(12), 2561–2568 (2003).
   PubMed Web of Science ®Google Scholar
• Jy W , JohansenME, BidotCJret al. Red cell-derived microparticles (RMP) as haemostatic agent. Thromb. Haemost.110(4), 751–760 (2013).
   PubMedGoogle Scholar
• Tantawy AA , AdlyAA, IsmailEAet al. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: relation to cardiovascular complications. Platelets24(8), 605–614 (2013).
   PubMed Web of Science ®Google Scholar
• Belizaire RM , PrakashPS, RichterJRet al. Microparticles from stored red blood cells activate neutrophils and cause lung injury after hemorrhage and resuscitation. J. Am. Coll. Surg.214(4), 648–655 (2012).
   PubMed Web of Science ®Google Scholar
• Zecher D1 , CumpelikA, SchifferliJA. Erythrocyte-derived microvesicles amplify systemic inflammation by thrombin-dependent activation of complement. Arterioscler. Thromb. Vasc. Biol.34(2), 313–320 (2014).
   PubMed Web of Science ®Google Scholar